EUROPEAN JOURNAL OF CANCER

Edit Your Profile

EUROPEAN JOURNAL OF CANCER Journal

publication venue for

1106 Amifostine (A), cisplatin (C), Vinblastine (V): A highly active regimen for non small cell lung cancer (NSCLC). 31:s230. 1995
Phase I trial of pixy321 in combination with cyclophosphamide (Cy) and carboplatin (Carb) in women with ovarian cancer (OC). 29:s52. 1993
Phase II trial of pembrolizumab in patients with solid tumors functionally competent or deficient for the Fanconi Anemia repair pathway 2018
Does valproic acid improve survival in glioblastoma? A meta-analysis of randomized trials in newly diagnosed glioblastoma 2015
Continuous combined oestrogen plus progestin and endometrial cancer in postmenopausal women in the Women's Health Initiative randomized clinical trial 2013
A Revised RTOG Recursive Partitioning Analysis (RPA) Model for Glioblastoma Based Upon Multi-Platform Biomarker Profiles 2012
Clinical, Molecular, and Molecular-Clinical Profile (MCP) Exploratory Subset Analysis of RTOG 0525: a Phase III Trial Comparing Standard (std) Adjuvant Temozolomide (TMZ) with a Dose-dense (dd) Schedule for Glioblastoma (GBM) 2011
Neurocognitive Function (NCF) Impairment Following Fractionated Stereotactic Radiotherapy (FSRT) for Benign or Low-Grade Adult Brain Tumours 2011
Optimizing Treatment for Gliomas - Radiotherapy 2011
Amifostine (A), cisplatin (C), vinblastine (V): A highly active regimen for non small cell lung cancer (NSCLC) 1995

category

ONCOLOGY Category

International Standard Serial Number (ISSN)

0959-8049

Electronic International Standard Serial Number (EISSN)

1879-0852

journal abbreviation

EUR J CANCER